Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.
Tamai H, Shimizu R, Shingaki N, Mori Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.
Tamai H, et al. Among authors: moribata k.
Hepat Res Treat. 2014;2014:748935. doi: 10.1155/2014/748935. Epub 2014 Sep 28.
Hepat Res Treat. 2014.
PMID: 25328696
Free PMC article.